Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_assertion type Assertion NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_head.
- NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_assertion description "[ It is concluded that genotyping for ABCB1 1236C>T may be one of the factors assisting with dose optimization of irinotecan chemotherapy in cancer patients. Additional investigation is required to confirm these findings in a larger population and to asses]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_provenance.
- NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_assertion evidence source_evidence_literature NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_provenance.
- NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_assertion SIO_000772 12960109 NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_provenance.
- NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_assertion wasDerivedFrom gad-20150221 NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_provenance.
- NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_assertion wasGeneratedBy ECO_0000203 NP61300.RAu0kAsb80znkh-50HokEMSaCcx4F1wZAAmwFK1ptBLJ0130_provenance.